Menu Search
Equities

Immunotech Biopharm Ltd

6978:HKG.HZ

Immunotech Biopharm Ltd

Actions
  • Price (HKD)3.19
  • Today's Change-0.11 / -3.33%
  • Shares traded108.00k
  • 1 Year change-12.84%
  • Beta--
Data delayed at least 15 minutes, as of May 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Immunotech Biopharm Ltd is a China-based investment holding company mainly engaged in the research and development, manufacturing and commercialization of immune cell products for treatments of cancers. Its main products are EAL, CAR-T cell series and TCR-T cell series products. EAL is a multi-target cellular immunotherapy product. It also provides cell cryopreservation services. The Company mainly conducts its businesses in the domestic market.

  • Revenue in HKD (TTM)0.00
  • Net income in HKD-361.63m
  • Incorporated2018
  • Employees210.00
  • Location
    Immunotech Biopharm Ltd8th Floor, Building 1Guosheng Science and Technology ParkNo.1 Kangding Street, Economic and TechnBeijing ChinaCHN
  • Websitehttp://www.eaal.net/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.